PEACE-1: Identifying Prognostic and Predictive Biomarkers for SOC Treatment of mCSPC

PEACE-1: Identifying Prognostic and Predictive Biomarkers for SOC Treatment of mCSPC

PEACE-1: prognostic biomarkers in de novo metastatic prostate cancerПодробнее

PEACE-1: prognostic biomarkers in de novo metastatic prostate cancer

Biomarkers In Breast Cancer - diagnostic prognostic and predictive biomarkers in breast cancerПодробнее

Biomarkers In Breast Cancer - diagnostic prognostic and predictive biomarkers in breast cancer

ProsTIC24 - Edmond Kwan: Prognostic and Predictive Biomarkers for PSMA Theranostics - ctDNAПодробнее

ProsTIC24 - Edmond Kwan: Prognostic and Predictive Biomarkers for PSMA Theranostics - ctDNA

Identifying predictive biomarkers of patient... - Philippos Tsourkas - TransMed - ISMB/ECCB 2023Подробнее

Identifying predictive biomarkers of patient... - Philippos Tsourkas - TransMed - ISMB/ECCB 2023

PEACE-1 trialПодробнее

PEACE-1 trial

Andrew Armstrong - Prognostic, predictive, and surrogate biomarkers...Подробнее

Andrew Armstrong - Prognostic, predictive, and surrogate biomarkers...

Lecture 1. Introducing imaging biomarkers for prostate cancer careПодробнее

Lecture 1. Introducing imaging biomarkers for prostate cancer care

PACE: prognostic and predictive biomarkers in ER+/HER2- advanced breast cancerПодробнее

PACE: prognostic and predictive biomarkers in ER+/HER2- advanced breast cancer

Prognostic biomarkers to guide treatment of mCRPCПодробнее

Prognostic biomarkers to guide treatment of mCRPC

Biomarkers for Prostate Cancer: Whom to TreatПодробнее

Biomarkers for Prostate Cancer: Whom to Treat

Prognostic biomarkers for prostate cancerПодробнее

Prognostic biomarkers for prostate cancer

ProsTIC24 - James Buteau: Prognostic & Predictive Biomarkers with PET for Lutetium-PSMA TheranosticsПодробнее

ProsTIC24 - James Buteau: Prognostic & Predictive Biomarkers with PET for Lutetium-PSMA Theranostics

Early Treatment Intensification for mCSPC: Optimising Patient Selection and TreatmentПодробнее

Early Treatment Intensification for mCSPC: Optimising Patient Selection and Treatment

PEACE-1: 8-month PSA determines outcomes in men with mCSPCПодробнее

PEACE-1: 8-month PSA determines outcomes in men with mCSPC

Diagnostic and Prognostic Biomarkers for Prostate CancerПодробнее

Diagnostic and Prognostic Biomarkers for Prostate Cancer

Diagnostic and Prognostic BiomarkersПодробнее

Diagnostic and Prognostic Biomarkers

New Prognostic Biomarkers - Ronald DePinho, MDПодробнее

New Prognostic Biomarkers - Ronald DePinho, MD

64- Predictive and Prognostic ToolsПодробнее

64- Predictive and Prognostic Tools